Kevin P. Fahey

Illumisonics, Inc. develops and patents advanced optical imaging systems for pre-clinical and clinical applications. The company was founded in 2014 and is based in Waterloo, Canada, where it has offices and R&D facilities. Illumisonics' executive team has a track record of successfully building companies and improving outcomes for clinicians and patients. The Canadian company's technical R & D teams are pioneers in pars technology, which captures all light-matter interactions to yield unprecedented cellular and molecular information. Illumisonics works with market-leading partners to develop systems for specific applications. The company's goal is to enable medical personnel to drive better healthcare outcomes for patients while enhancing decision-making and reducing costs. The company was founded by Parsin Haji Reza, and the CEO is Scott C. Durbin.

Illumisonics, Inc. develops and patents advanced optical imaging systems for pre-clinical and clinical applications. The company was founded in 2014 and is based in Waterloo, Canada, where it has offices and R&D facilities. Illumisonics' executive team has a track record of successfully building companies and improving outcomes for clinicians and patients. The Canadian company's technical R & D teams are pioneers in pars technology, which captures all light-matter interactions to yield unprecedented cellular and molecular information. Illumisonics works with market-leading partners to develop systems for specific applications. The company's goal is to enable medical personnel to drive better healthcare outcomes for patients while enhancing decision-making and reducing costs. The company was founded by Parsin Haji Reza, and the CEO is Scott C. Durbin.

Illumisonics, Inc. develops and patents advanced optical imaging systems for pre-clinical and clinical applications. The company was founded in 2014 and is based in Waterloo, Canada, where it has offices and R&D facilities. Illumisonics' executive team has a track record of successfully building companies and improving outcomes for clinicians and patients. The Canadian company's technical R & D teams are pioneers in pars technology, which captures all light-matter interactions to yield unprecedented cellular and molecular information. Illumisonics works with market-leading partners to develop systems for specific applications. The company's goal is to enable medical personnel to drive better healthcare outcomes for patients while enhancing decision-making and reducing costs. The company was founded by Parsin Haji Reza, and the CEO is Scott C. Durbin.

Illumisonics, Inc. develops and patents advanced optical imaging systems for pre-clinical and clinical applications. The company was founded in 2014 and is based in Waterloo, Canada, where it has offices and R&D facilities. Illumisonics' executive team has a track record of successfully building companies and improving outcomes for clinicians and patients. The Canadian company's technical R & D teams are pioneers in pars technology, which captures all light-matter interactions to yield unprecedented cellular and molecular information. Illumisonics works with market-leading partners to develop systems for specific applications. The company's goal is to enable medical personnel to drive better healthcare outcomes for patients while enhancing decision-making and reducing costs. The company was founded by Parsin Haji Reza, and the CEO is Scott C. Durbin.

Illumisonics, Inc. develops and patents advanced optical imaging systems for pre-clinical and clinical applications. The company was founded in 2014 and is based in Waterloo, Canada, where it has offices and R&D facilities. Illumisonics' executive team has a track record of successfully building companies and improving outcomes for clinicians and patients. The Canadian company's technical R & D teams are pioneers in pars technology, which captures all light-matter interactions to yield unprecedented cellular and molecular information. Illumisonics works with market-leading partners to develop systems for specific applications. The company's goal is to enable medical personnel to drive better healthcare outcomes for patients while enhancing decision-making and reducing costs. The company was founded by Parsin Haji Reza, and the CEO is Scott C. Durbin.